| Date Filed | Type | Description |
| 10/05/2023 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 100,450 options to buy
@ $6.41, valued at
$643.9k
|
|
| 05/02/2023 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 88,077 shares
@ $0
Sold 23,753 shares
@ $3.85, valued at
$91.4k
Sold 3,641 shares
@ $3.76, valued at
$13.7k
|
|
| 12/14/2022 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 45,000 options to buy
@ $3.11, valued at
$140k
|
|
| 02/18/2022 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 505,000 options to buy
@ $0.791, valued at
$399.5k
|
|
| 02/11/2022 |
SC 13G/A
| Luthringer Remy reports a 2.5% stake in Minerva Neurosciences, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/16/2020 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Sold 1,300 shares
@ $2.64, valued at
$3.4k
Exercised 18,750 restricted stock units
@ $0 |
|
| 10/14/2020 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.5, valued at
$700k
|
|
| 08/17/2020 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 354,302 options to buy
@ $7.11, valued at
$2.5M
|
|
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Sold 2,412 shares
@ $7.1, valued at
$17.1k
Exercised 18,750 restricted stock units
@ $0 |
|
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/18/2018 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Sold 2,604 shares
@ $7.46, valued at
$19.4k
Exercised 18,750 restricted stock units
@ $0 |
|
| 12/13/2018 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 410,000 options to buy
@ $7.96, valued at
$3.3M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2017 |
4
| Luthringer Remy (CEO) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Sold 2,194 shares
@ $5.85, valued at
$12.8k
Granted 350,000 options to buy
@ $6.1, valued at
$2.1M
Exercised 18,750 restricted stock units
@ $0 |
|
| 02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/17/2014 |
SC 13D
| Luthringer Remy reports a 7% stake in Minerva Neurosciences, Inc. |